SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
CG Oncology engaged legal counsel for an Offering of Shares pursuant to an Open Market Sale Agreement. As a biopharma developer of drugs for urothelia...
Arteris, Inc. announced it has hired Saurabh Sinha as its Chief Financial Officer, effective September 2, 2026. He will replace outgoing leadership an...
Maximus reported stronger Q3 2026 diluted EPS than the prior year and updated its full-year revenue and adjusted EPS guidance upward amid AI adoption ...
Oncor Electric Delivery reports second-quarter 2026 net income of $428 million, up $169 million from the prior year, driven by higher regulated revenu...
Ensysce Biosciences, Inc. entered into an agreement and plan of merger with Cy Biopharma, Inc. The deal documents a strategic combination filed with t...
The company reports rapid clinical improvements in all ten patients from its FORWARD study for tanruprubart. The positive trial data reinforce the dru...
Cra International recorded record revenue and earnings for Q2 2026, increasing full-year revenue guidance and reaffirming profit margin targets....
Corbus Pharmaceuticals secured FDA clearance for the Phase 3 TEMPO-1 study of CRB-701 in oropharyngeal cancer and announced leadership appointments to...
Vivani Medical announced successful dosing of all SLIM-1 trial participants, evaluating its NPM-139 implant ahead of schedule. With data expected in 2...
NetScout reported a 12.7% increase in total revenue to $210.4 million and reaffirmed its full-year outlook, driven by strong demand for Service Assura...
Institutional holdings report (13F-HR) filed by Working Capital Advisors. Ticker: UK....
Theriva Biologics announced the dosing of the first patient in the VIRAGE2 trial to evaluate more frequent dosing of VCN-01 in first-line metastatic p...
Delcath reported a 20% increase in Q2 2026 revenue driven by HEPZATO procedures; the company raised its full year 2026 revenue guidance to a range of ...
Chegg reported a 51% year-over-year revenue decrease to $51.8 million but outperformed adjusted EBITDA expectations at $9.1 million. The company antic...
Centrus Energy Corp. announced a signed contract with X-energy to provide low- and high-assay, low-enriched uranium; the deal boosts the company's bac...
RL reported better-than-expected first quarter fiscal 2027 results and raised its full year outlook due to strong consumer demand in Asia and North Am...
Fox Corporation reported Q4 FY2026 revenue of $4.21 billion and net income of $696 million, returning to positive growth momentum and achieving record...
Helix Energy Solutions Group reported second quarter 2026 net income of $22.7 million, or $0.15 per diluted share, with adjusted EBITDA rising to $69....
Edgewise announced positive Phase 2 CIRRUS-HCM data for EDG-7500 and finalized the sale of sevasemten to Servier for up to $2.65 billion, significantl...
The company filed an unaudited pro forma balance sheet as of June 30, 2026, to present the financial impact of a proposed transaction and related adju...